RIFATER Side Effects

6970183-8 | Eosinophilia, Erythema, Hepatic Enzyme Increased, Hyperthermia
on Sep 03, 2010 Male patient from FRANCE , 83 years of age, was diagnosed with gastric tube reconstruction and was treated with Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilia, erythema, hepatic enzyme increased, hyperthermia. Rifater dosage: Dose:5 Unit(s). During the same period patient was treated with RIFAMATE (View Rifamate Review and Rifamate Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), VITAMINES B1 B6 (Dose:3 Unit(s)) (View Vitamines B1 B6 Review and Vitamines B1 B6 Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), LASIX (View Lasix Review and Lasix Label ), DIFFU K (View Diffu K Review and Diffu K Label ), MOPRAL (View Mopral Review and Mopral Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6938280-0 | Asthenia, Goodpasture's Syndrome, Renal Failure Acute
Patient was taking Rifater (View Usage). Patient had the following side effects: asthenia, goodpasture's syndrome, renal failure acute on Aug 18, 2010 from FRANCE Additional patient health information: Male patient , 61 years of age, was diagnosed with hyperuricaemia and. Rifater dosage: . During the same period patient was treated with RIFAMATE (View Rifamate Review and Rifamate Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), COLCHIMAX (View Colchimax Review and Colchimax Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), NOVOMIX 30 (View Novomix 30 Review and Novomix 30 Label ), STAGID (View Stagid Review and Stagid Label ). Patient was hospitalized.

6931618-X | Hepatitis B, Hepatocellular Injury
Adverse event was reported on Aug 09, 2010 by a Male patient taking Rifater (View Usage) (Dosage: ) . Location: FRANCE , 22 years of age, weighting 132.3 lb, After Rifater was administered, patient had the following side effects: hepatitis b (What is hepatitis b?), hepatocellular injury. During the same period patient was treated with MYAMBUTOL (View Myambutol Review and Myambutol Label ). Patient was hospitalized.

6760493-1 | Immune Reconstitution Syndrome, Impaired Gastric Emptying, Lymphadenopathy
on May 27, 2010 Female patient from UNITED KINGDOM , 34 years of age, was diagnosed with tuberculosis (What is tuberculosis?), hiv infection (What is hiv infection?) and was treated with Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: immune reconstitution syndrome, impaired gastric emptying, lymphadenopathy. Rifater dosage: Dose:4 Unit(s). During the same period patient was treated with PREDNISOLONE METASULPHOBENZOATE SODIUM (View Prednisolone Metasulphobenzoate Sodium Review and Prednisolone Metasulphobenzoate Sodium Label ), EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (Dose:1 Unit(s)) (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ), SUSTIVA (Dose:1 Unit(s)) (View Sustiva Review and Sustiva Label ), FUZEON (Dose Unit: 90 Mg/ml) (View Fuzeon Review and Fuzeon Label ), MYAMBUTOL (Dose:2 Unit(s)) (View Myambutol Review and Myambutol Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), BACTRIM (Dose:1 Unit(s)) (View Bactrim Review and Bactrim Label ). Patient was hospitalized and became disabled.


6741391-6 | Sinus Tachycardia
on Nov 24, 2009 Female patient from SPAIN , 53 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifater (View Usage). Patient had the following side effects: sinus tachycardia. Rifater dosage: .

6593237-7 | Cytolytic Hepatitis, Eosinophilia, Hepatic Failure, Lymphadenopathy, Pyrexia, Rash
Patient was taking Rifater (View Usage). After Rifater was administered, patient had the following side effects: cytolytic hepatitis, eosinophilia, hepatic failure, lymphadenopathy, pyrexia, rash (What is rash?) on Feb 12, 2010 from FRANCE Additional patient health information: Male patient , 55 years of age, weighting 138.9 lb, was diagnosed with pulmonary tuberculosis, delirium and. Rifater dosage: Dose:6 Unit(s). During the same period patient was treated with MYAMBUTOL (Dose:3 Unit(s)) (View Myambutol Review and Myambutol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMLOR (View Amlor Review and Amlor Label ), HALDOL (View Haldol Review and Haldol Label ), LEPTICUR (View Lepticur Review and Lepticur Label ), VASELINE (View Vaseline Review and Vaseline Label ), DEXERYL ^PIERRE FABRE^ (View Dexeryl ^pierre Fabre^ Review and Dexeryl ^pierre Fabre^ Label ), EFFICORT (View Efficort Review and Efficort Label ). Patient was hospitalized.

6575125-5 | Cytolytic Hepatitis, Eosinophilia, Hepatic Failure, Lymphadenopathy, Pyrexia, Rash
Adverse event was reported on Feb 03, 2010 by a Male patient taking Rifater (View Usage) (Dosage: Dose:6 Unit(s)) was diagnosed with pulmonary tuberculosis, delirium and. Location: FRANCE , 55 years of age, weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, eosinophilia, hepatic failure, lymphadenopathy, pyrexia, rash (What is rash?). During the same period patient was treated with MYAMBUTOL (Dose:3 Unit(s)) (View Myambutol Review and Myambutol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMLOR (View Amlor Review and Amlor Label ), HALDOL (View Haldol Review and Haldol Label ), LEPTICUR (View Lepticur Review and Lepticur Label ). Patient was hospitalized.

6541908-0 | Cytolytic Hepatitis, Eosinophilia, Hepatic Failure, Lymphadenopathy, Pyrexia, Rash
on Jan 08, 2010 Male patient from FRANCE , 55 years of age, weighting 138.9 lb, was diagnosed with pulmonary tuberculosis and was treated with Rifater (View Usage). Patient had the following side effects: cytolytic hepatitis, eosinophilia, hepatic failure, lymphadenopathy, pyrexia, rash (What is rash?). Rifater dosage: . During the same period patient was treated with MYAMBUTOL (View Myambutol Review and Myambutol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6479899-3 | Eosinophilia, Erythema, Hepatic Enzyme Increased, Hyperthermia
on Nov 05, 2009 Male patient from FRANCE , 83 years of age, was diagnosed with gastric tube reconstruction and was treated with Rifater (View Usage). After Rifater was administered, patient had the following side effects: eosinophilia, erythema, hepatic enzyme increased, hyperthermia. Rifater dosage: Dose:5 Unit(s). During the same period patient was treated with RIFINAH (View Rifinah Review and Rifinah Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), VITAMINES B1 B6 (Dose:3 Unit(s)) (View Vitamines B1 B6 Review and Vitamines B1 B6 Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), LASILIX (View Lasilix Review and Lasilix Label ), DIFFU K (View Diffu K Review and Diffu K Label ), MOPRAL (View Mopral Review and Mopral Label ), TEMESTA (View Temesta Review and Temesta Label ). Patient was hospitalized.

6380511-2 | Cytolytic Hepatitis, Eosinophilia, Lymphadenopathy, Pyrexia, Rash Maculo-papular, Splenomegaly
Patient was taking Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, eosinophilia, lymphadenopathy, pyrexia, rash maculo-papular, splenomegaly on Sep 16, 2009 from Additional patient health information: Female patient , 16 years of age, was diagnosed with pulmonary tuberculosis and. Rifater dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PIRILENE (View Pirilene Review and Pirilene Label ), RIFADIN (View Rifadin Review and Rifadin Label ), RIMIFON (View Rimifon Review and Rimifon Label ), CLAMOXYL /00249601/ (View Clamoxyl /00249601/ Review and Clamoxyl /00249601/ Label ), FUMAFER (View Fumafer Review and Fumafer Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

6356533-4 | Cough, Headache, Influenza, Pyrexia, Toxic Skin Eruption
Adverse event was reported on Sep 09, 2009 by a Male patient taking Rifater (View Usage) (Dosage: ) was diagnosed with tuberculosis (What is tuberculosis?) and. Location: , 30 years of age, Patient had the following side effects: cough, headache (What is headache?), influenza, pyrexia, toxic skin eruption. During the same period patient was treated with ORBENIN CAP (View Orbenin Cap Review and Orbenin Cap Label ), BACTRIM (View Bactrim Review and Bactrim Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), DAFALGAN /00020001/ (View Dafalgan /00020001/ Review and Dafalgan /00020001/ Label ). Patient was hospitalized.

6328876-1 | Anaemia, Body Temperature Decreased, Condition Aggravated, Dysaesthesia, Food Intolerance, Hepatic Necrosis, Hilar Lymphadenopathy
on Aug 20, 2009 Female patient from FRANCE , 34 years of age, was diagnosed with tuberculosis (What is tuberculosis?), hiv infection (What is hiv infection?), prophylaxis and was treated with Rifater (View Usage). After Rifater was administered, patient had the following side effects: anaemia, body temperature decreased, condition aggravated, dysaesthesia, food intolerance, hepatic necrosis, hilar lymphadenopathy. Rifater dosage: Dose: 4 Df. During the same period patient was treated with TRUVADA (Dose: 1 Df) (View Truvada Review and Truvada Label ), SUSTIVA (Dose: 1 Df) (View Sustiva Review and Sustiva Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), MYAMBUTOL (Dose: 2 Df) (View Myambutol Review and Myambutol Label ), SPECIAFOLDINE (Dose: 1 Df) (View Speciafoldine Review and Speciafoldine Label ), BACTRIM (Dose: 1 Df) (View Bactrim Review and Bactrim Label ), PIRILENE (View Pirilene Review and Pirilene Label ). Patient was hospitalized and became disabled.

6190100-0 | Immune Reconstitution Syndrome, Impaired Gastric Emptying, Lymphadenopathy
on May 08, 2009 Female patient from FRANCE , 34 years of age, was diagnosed with tuberculosis (What is tuberculosis?), hiv infection (What is hiv infection?) and was treated with Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: immune reconstitution syndrome, impaired gastric emptying, lymphadenopathy. Rifater dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), SOLUPRED /00016201/ (View Solupred /00016201/ Review and Solupred /00016201/ Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized and became disabled.

6182966-5 | Immune Reconstitution Syndrome, Impaired Gastric Emptying, Lymphadenopathy
Patient was taking Rifater (View Usage). Patient had the following side effects: immune reconstitution syndrome, impaired gastric emptying, lymphadenopathy on Apr 30, 2009 from FRANCE Additional patient health information: Female patient , 34 years of age, was diagnosed with tuberculosis (What is tuberculosis?), hiv infection (What is hiv infection?), prophylaxis and. Rifater dosage: Dose: 4 Df. During the same period patient was treated with TRUVADA (Dose: 1 Df) (View Truvada Review and Truvada Label ), SUSTIVA (Dose: 1 Df) (View Sustiva Review and Sustiva Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), MYAMBUTOL (Dose: 2 Df) (View Myambutol Review and Myambutol Label ), FOLIC ACID (Dose: 1 Df) (View Folic Acid Review and Folic Acid Label ), BACTRIM (Dose: 1 Df) (View Bactrim Review and Bactrim Label ). Patient was hospitalized and became disabled.

6119359-2 | C-reactive Protein Increased, Pyrexia
Adverse event was reported on Mar 05, 2009 by a Female patient taking Rifater (View Usage) (Dosage: ) was diagnosed with tuberculosis (What is tuberculosis?), hypothyroidism and. Location: , 82 years of age, After Rifater was administered, patient had the following side effects: c-reactive protein increased, pyrexia. During the same period patient was treated with MYAMBUTOL (View Myambutol Review and Myambutol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PROZAC (View Prozac Review and Prozac Label ), TEMESTA /00273201/ (View Temesta /00273201/ Review and Temesta /00273201/ Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASILIX FAIBLE (View Lasilix Faible Review and Lasilix Faible Label ), SOTALEX (View Sotalex Review and Sotalex Label ), CALCIUM WITH VITAMIN D /01233101/ (View Calcium With Vitamin D /01233101/ Review and Calcium With Vitamin D /01233101/ Label ). Patient was hospitalized.

6093499-9 | Immune Reconstitution Syndrome, Lymphadenopathy
on Feb 18, 2009 Male patient from FRANCE , 34 years of age, was diagnosed with tuberculosis (What is tuberculosis?), hiv infection (What is hiv infection?), prophylaxis and was treated with Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: immune reconstitution syndrome, lymphadenopathy. Rifater dosage: Dose: 4 Df. During the same period patient was treated with TRUVADA (Dose: 1 Df) (View Truvada Review and Truvada Label ), SUSTIVA (Dose: 1 Df) (View Sustiva Review and Sustiva Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), MYAMBUTOL (Dose: 2 Df) (View Myambutol Review and Myambutol Label ), FOLIC ACID (Dose: 1 Df) (View Folic Acid Review and Folic Acid Label ), BACTRIM (Dose: 1 Df) (View Bactrim Review and Bactrim Label ). Patient was hospitalized and became disabled.

6048623-0 | Multi-organ Failure, Rash Maculo-papular
on Jan 15, 2009 Female patient from , 65 years of age, was treated with Rifater (View Usage). Patient had the following side effects: multi-organ failure, rash maculo-papular. Rifater dosage: . During the same period patient was treated with MYAMBUTOL (View Myambutol Review and Myambutol Label ), BACTRIM (View Bactrim Review and Bactrim Label ), LAROXYL (View Laroxyl Review and Laroxyl Label ), IMOVANE (View Imovane Review and Imovane Label ). Patient was hospitalized.

5944834-0 | Abdominal Pain, Blood Amylase Increased, C-reactive Protein Increased, Lipase Increased, Pancreatitis Acute, Pyrexia, Vomiting
Patient was taking Rifater (View Usage). After Rifater was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood amylase increased, c-reactive protein increased, lipase increased, pancreatitis acute, pyrexia, vomiting on Oct 30, 2008 from Additional patient health information: Male patient , 41 years of age, . Rifater dosage: . During the same period patient was treated with REYATAZ (View Reyataz Review and Reyataz Label ), TRUVADA (View Truvada Review and Truvada Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), MOVICOL /01053601/ (View Movicol /01053601/ Review and Movicol /01053601/ Label ), SPAGULAX (View Spagulax Review and Spagulax Label ). Patient was hospitalized.

5941851-1 | Acute Hepatic Failure, Jaundice, Multi-organ Failure
Adverse event was reported on Oct 28, 2008 by a Male patient taking Rifater (View Usage) (Dosage: Dose: 1 Tablet 5x Daily) was diagnosed with tuberculosis (What is tuberculosis?) and. Location: SPAIN , 56 years of age, Patient experienced the following unwanted or unexpected effects: acute hepatic failure, jaundice (What is jaundice?), multi-organ failure.

5940355-X | Linear Iga Disease, Pneumonia
on Oct 28, 2008 Male patient from , 84 years of age, was diagnosed with unevaluable event and was treated with Rifater (View Usage). Patient had the following side effects: linear iga disease, pneumonia (What is pneumonia?). Rifater dosage: . During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ).

5926671-6 | Acidosis, Malaise, Nausea
on Oct 14, 2008 Male patient from SPAIN , 44 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifater (View Usage). After Rifater was administered, patient had the following side effects: acidosis, malaise, nausea (What is nausea?). Rifater dosage: Dose: 1 Tbl. During the same period patient was treated with METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), COPEGUS (View Copegus Review and Copegus Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), PEGASYS (View Pegasys Review and Pegasys Label ), REXER (View Rexer Review and Rexer Label ), TRANKIMAZIN (View Trankimazin Review and Trankimazin Label ). Patient was hospitalized.

5840281-0 | Abdominal Pain, Gallbladder Disorder, Hepatic Encephalopathy, Hepatic Failure, Hypoglycaemia, Menorrhagia, Oliguria, Prothrombin Time Abnormal, Pyrexia
Patient was taking Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), gallbladder disorder, hepatic encephalopathy, hepatic failure, hypoglycaemia, menorrhagia, oliguria, prothrombin time abnormal, pyrexia on Jul 31, 2008 from SWITZERLAND Additional patient health information: Female patient , 34 years of age, weighting 154.3 lb, . Rifater dosage: Dose: 50/300/0.17/120. During the same period patient was treated with ETHAMBUTOL HCL (View Ethambutol Hcl Review and Ethambutol Hcl Label ). Patient was hospitalized.

5746683-5 | Coombs Positive Haemolytic Anaemia, Hepatocellular Injury, Renal Failure Acute, Systemic Inflammatory Response Syndrome, Thrombocytopenia
Adverse event was reported on May 15, 2008 by a Male patient taking Rifater (View Usage) (Dosage: Dose Quantity: 1) . Location: SWITZERLAND , 58 years of age, Patient had the following side effects: coombs positive haemolytic anaemia, hepatocellular injury, renal failure acute, systemic inflammatory response syndrome, thrombocytopenia. During the same period patient was treated with MYAMBUTOL (View Myambutol Review and Myambutol Label ). Patient was hospitalized.

5684393-3 | Hepatocellular Injury, Oedematous Pancreatitis
on Mar 25, 2008 Female patient from , 76 years of age, was treated with Rifater (View Usage). After Rifater was administered, patient had the following side effects: hepatocellular injury, oedematous pancreatitis. Rifater dosage: . During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), DEXAMBUTOL (View Dexambutol Review and Dexambutol Label ), TENORMIN (View Tenormin Review and Tenormin Label ), NEXIUM (View Nexium Review and Nexium Label ), ATARAX /00058402/ (View Atarax /00058402/ Review and Atarax /00058402/ Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), IMOVANE (View Imovane Review and Imovane Label ). Patient was hospitalized.

5643156-5 | Immune Reconstitution Syndrome
on Feb 20, 2008 Male patient from FRANCE , 51 years of age, was diagnosed with tuberculosis (What is tuberculosis?), hiv infection (What is hiv infection?) and was treated with Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: immune reconstitution syndrome. Rifater dosage: . During the same period patient was treated with PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), TRUVADA (View Truvada Review and Truvada Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), DEXAMBUTOL (View Dexambutol Review and Dexambutol Label ), RIFINAH (View Rifinah Review and Rifinah Label ). Patient was hospitalized.

5580122-2 | Cardio-respiratory Arrest, Thrombocytopenia, Vascular Purpura
Patient was taking Rifater (View Usage). Patient had the following side effects: cardio-respiratory arrest, thrombocytopenia, vascular purpura on Dec 26, 2007 from Additional patient health information: Female patient , 61 years of age, . Rifater dosage: . During the same period patient was treated with HEPARINA CHOAY (View Heparina Choay Review and Heparina Choay Label ), DEPAMIDE (View Depamide Review and Depamide Label ), LOXEN (View Loxen Review and Loxen Label ), ATHYMIL (View Athymil Review and Athymil Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

5519289-0 | Anorexia, Hepatitis, Hepatocellular Damage, Malaise, Pyrexia, Weight Decreased
Adverse event was reported on Nov 06, 2007 by a Male patient taking Rifater (View Usage) (Dosage: ) was diagnosed with tuberculosis (What is tuberculosis?) and. Location: , 32 years of age, After Rifater was administered, patient had the following side effects: anorexia, hepatitis (What is hepatitis?), hepatocellular damage, malaise, pyrexia, weight decreased. During the same period patient was treated with RIFINAH (View Rifinah Review and Rifinah Label ), KETAMINE HCL (View Ketamine Hcl Review and Ketamine Hcl Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), TRUVADA (View Truvada Review and Truvada Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ). Patient was hospitalized.

5423598-3 | Polyarthritis
on Aug 14, 2007 Male patient from , 63 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: polyarthritis. Rifater dosage: . Patient was hospitalized.

5392164-0 | Arthritis, Haemorrhage
on Jul 10, 2007 Male patient from CHINA , 79 years of age, was diagnosed with pulmonary tuberculosis, prophylaxis, fungal infection (What is fungal infection?) and was treated with Rifater (View Usage). Patient had the following side effects: arthritis (What is arthritis?), haemorrhage. Rifater dosage: . During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), CEFOPERAZONE SODIUM (View Cefoperazone Sodium Review and Cefoperazone Sodium Label ), SULBACTAM (View Sulbactam Review and Sulbactam Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), MYCOSTATIN /00036501/ (View Mycostatin /00036501/ Review and Mycostatin /00036501/ Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

5295872-5 | Blister, Pruritus
Patient was taking Rifater (View Usage). After Rifater was administered, patient had the following side effects: blister, pruritus on Apr 05, 2007 from Additional patient health information: Female patient , 62 years of age, weighting 116.8 lb, was diagnosed with pulmonary tuberculosis and. Rifater dosage: Dose: 5 Df. Patient was hospitalized.

5275512-1 | Acute Hepatic Failure, Dialysis, Hepatic Steatosis, Hyponatraemia, Liver Transplant, Pleural Effusion, Post Procedural Haemorrhage, Rash
Adverse event was reported on Mar 16, 2007 by a Male patient taking Rifater (View Usage) (Dosage: Dose: Not Reported) was diagnosed with pulmonary tuberculosis and. Location: GERMANY , 31 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: acute hepatic failure, dialysis (What is dialysis?), hepatic steatosis, hyponatraemia, liver transplant (What is liver transplant?), pleural effusion, post procedural haemorrhage, rash (What is rash?). Patient was hospitalized.

5230429-3 | Abortion Spontaneous, Placental Disorder
on Feb 01, 2007 Female patient from , 24 years of age, was diagnosed with lymph node tuberculosis and was treated with Rifater (View Usage). Patient had the following side effects: abortion spontaneous, placental disorder. Rifater dosage: . Patient was hospitalized.

5214112-6 | Dermatitis Bullous, Epistaxis, Mouth Haemorrhage, Thrombocytopenic Purpura
on Jan 15, 2007 Male patient from FRANCE , 73 years of age, was diagnosed with tuberculous pleurisy and was treated with Rifater (View Usage). After Rifater was administered, patient had the following side effects: dermatitis bullous, epistaxis, mouth haemorrhage, thrombocytopenic purpura. Rifater dosage: . During the same period patient was treated with AMLOR (View Amlor Review and Amlor Label ), ALDALIX (View Aldalix Review and Aldalix Label ), PERMIXON /00833501/ (View Permixon /00833501/ Review and Permixon /00833501/ Label ), VITAMIN B1 AND B6 (View Vitamin B1 And B6 Review and Vitamin B1 And B6 Label ). Patient was hospitalized.

5196688-0 | Abortion Spontaneous
Patient was taking Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous on Dec 26, 2006 from Additional patient health information: Female patient , 24 years of age, was diagnosed with lymph node tuberculosis and. Rifater dosage: . Patient was hospitalized.

5166673-3 | Hepatitis Toxic, Hypoglycaemia, Shock
Adverse event was reported on Nov 23, 2006 by a Female patient taking Rifater (View Usage) (Dosage: Dose: 1 Df) was diagnosed with pulmonary tuberculosis, hypertension and. Location: SWITZERLAND , 79 years of age, Patient had the following side effects: hepatitis toxic, hypoglycaemia, shock. During the same period patient was treated with MYAMBUTOL (View Myambutol Review and Myambutol Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

5123788-3 | Eosinophilia, Lung Abscess, Rash Maculo-papular, Toxic Skin Eruption, Urticaria
on Sep 28, 2006 Female patient from , 80 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifater (View Usage). After Rifater was administered, patient had the following side effects: eosinophilia, lung abscess, rash maculo-papular, toxic skin eruption, urticaria. Rifater dosage: . Patient was hospitalized.

5091676-7 | Cytolytic Hepatitis, Dermatitis Exfoliative, Eosinophilia, Hypersensitivity, Lymphadenopathy, Pyrexia, Systemic Inflammatory Response Syndrome, Transaminases Increased
on Aug 21, 2006 Female patient from , 48 years of age, was diagnosed with dermo-hypodermitis, urinary tract infection (What is urinary tract infection?), irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, dermatitis exfoliative, eosinophilia, hypersensitivity, lymphadenopathy, pyrexia, systemic inflammatory response syndrome, transaminases increased. Rifater dosage: . During the same period patient was treated with NOROXIN (View Noroxin Review and Noroxin Label ), DEBRIDAT (View Debridat Review and Debridat Label ), MOTILIUM (View Motilium Review and Motilium Label ), SPASFON (View Spasfon Review and Spasfon Label ). Patient was hospitalized.

5052496-2 | Blood Bilirubin Increased, Encephalopathy, Haemolysis, Renal Failure Acute
Patient was taking Rifater (View Usage). Patient had the following side effects: blood bilirubin increased, encephalopathy, haemolysis, renal failure acute on Jun 29, 1998 from Additional patient health information: Female patient , 73 years of age, . Rifater dosage: . During the same period patient was treated with DIAMICRON (View Diamicron Review and Diamicron Label ), LOVENOX (View Lovenox Review and Lovenox Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), COZAAR (View Cozaar Review and Cozaar Label ).

4964462-3 | Abortion Induced, Pregnancy
Adverse event was reported on Mar 27, 2006 by a Female patient taking Rifater (View Usage) (Dosage: ) was diagnosed with tuberculosis (What is tuberculosis?) and. Location: FRANCE , 30 years of age, After Rifater was administered, patient had the following side effects: abortion induced, pregnancy (What is pregnancy?).

4907857-6 | Chills, Dyspnoea, Erythema
on Jun 28, 2005 Female patient from , 20 years of age, weighting 112.4 lb, was diagnosed with pulmonary tuberculosis, epilepsy (What is epilepsy?) and was treated with Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: chills, dyspnoea, erythema. Rifater dosage: . During the same period patient was treated with URBANYL (View Urbanyl Review and Urbanyl Label ), SABRIL (View Sabril Review and Sabril Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.

4895447-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Cytolytic Hepatitis, Eosinophilia, Hepatic Failure, Lipase Increased
on Sep 13, 2005 Male patient from , 29 years of age, weighting 145.5 lb, was diagnosed with lymph node tuberculosis and was treated with Rifater (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cytolytic hepatitis, eosinophilia, hepatic failure, lipase increased. Rifater dosage: . Patient was hospitalized.

4884948-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Cytolytic Hepatitis, Eosinophilia, Hepatic Failure, Lipase Increased
Patient was taking Rifater (View Usage). After Rifater was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cytolytic hepatitis, eosinophilia, hepatic failure, lipase increased on Sep 13, 2005 from Additional patient health information: Male patient , 29 years of age, weighting 145.5 lb, was diagnosed with lymph node tuberculosis and. Rifater dosage: . Patient was hospitalized.

4852244-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Cytolytic Hepatitis, Eosinophilia, Hepatic Failure, Hepatic Trauma
Adverse event was reported on Sep 13, 2005 by a Male patient taking Rifater (View Usage) (Dosage: ) was diagnosed with lymph node tuberculosis and. Location: , 29 years of age, weighting 145.5 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cytolytic hepatitis, eosinophilia, hepatic failure, hepatic trauma. Patient was hospitalized.

4798368-X | Acidosis, Complex Partial Seizures, Confusional State, Convulsion, Lactic Acidosis, Muscle Twitching, Pulmonary Embolism, Pulmonary Oedema
on Jul 14, 2005 Female patient from SOUTH AFRICA , 50 years of age, was diagnosed with tuberculosis (What is tuberculosis?), infection (What is infection?), somnolence, diabetes mellitus and was treated with Rifater (View Usage). Patient had the following side effects: acidosis, complex partial seizures, confusional state, convulsion, lactic acidosis, muscle twitching, pulmonary embolism (What is pulmonary embolism?), pulmonary oedema. Rifater dosage: Dose: 4 Daily. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), IMOVANE (View Imovane Review and Imovane Label ), STILNOX (View Stilnox Review and Stilnox Label ), CIPROBAY (View Ciprobay Review and Ciprobay Label ), INSULIN (View Insulin Review and Insulin Label ), MAXOLON (View Maxolon Review and Maxolon Label ), SYNAP FORTE (View Synap Forte Review and Synap Forte Label ), PACKED BLOOD CELLS (View Packed Blood Cells Review and Packed Blood Cells Label ).

4777119-9 | Cheilitis, Hot Flush, Rash, Skin Disorder
on Sep 15, 2005 Female patient from , 55 years of age, weighting 121.3 lb, was diagnosed with renal tuberculosis and was treated with Rifater (View Usage). After Rifater was administered, patient had the following side effects: cheilitis, hot flush, rash (What is rash?), skin disorder. Rifater dosage: Dose: 5 Tab. During the same period patient was treated with PYRIDOXINE HCL (View Pyridoxine Hcl Review and Pyridoxine Hcl Label ).

4775751-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Hepatic Failure, Hepatitis, Hepatocellular Damage, Lipase Increased
Patient was taking Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, hepatic failure, hepatitis (What is hepatitis?), hepatocellular damage, lipase increased on Sep 13, 2005 from Additional patient health information: Male patient , 29 years of age, weighting 145.5 lb, was diagnosed with lymph node tuberculosis and. Rifater dosage: .

4734925-4 | Anorexia, Depression, Hepatitis Cholestatic, Renal Failure Acute
Adverse event was reported on Jul 28, 2005 by a Female patient taking Rifater (View Usage) (Dosage: ) . Location: , 69 years of age, Patient had the following side effects: anorexia, depression (What is depression?), hepatitis cholestatic, renal failure acute. During the same period patient was treated with FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), SECTRAL (View Sectral Review and Sectral Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PERSANTINE (View Persantine Review and Persantine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SINTROM (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

4731376-3 | Acidosis, Confusional State, Convulsion, Lymphocyte Count Increased, Pyrexia
on Jul 14, 2005 Female patient from SOUTH AFRICA , 50 years of age, was diagnosed with tuberculosis (What is tuberculosis?), somnolence, infection (What is infection?), diabetes mellitus and was treated with Rifater (View Usage). After Rifater was administered, patient had the following side effects: acidosis, confusional state, convulsion, lymphocyte count increased, pyrexia. Rifater dosage: Dose: 4 Daily. During the same period patient was treated with IMOVANE (View Imovane Review and Imovane Label ), CIPROBAY (View Ciprobay Review and Ciprobay Label ), STILNOX (View Stilnox Review and Stilnox Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), INSULIN (View Insulin Review and Insulin Label ).

4708618-3 | Burning Sensation, Chills, Dyspnoea, Erythema, Pruritus
on Jun 28, 2005 Female patient from , 20 years of age, weighting 112.4 lb, was diagnosed with pulmonary tuberculosis, epilepsy (What is epilepsy?) and was treated with Rifater (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, chills, dyspnoea, erythema, pruritus. Rifater dosage: . During the same period patient was treated with URBANYL (View Urbanyl Review and Urbanyl Label ), SABRIL (View Sabril Review and Sabril Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.

4685173-8 | Hypoacusis, Hypoaesthesia, Neuritis Cranial, Optic Neuritis, Visual Acuity Reduced
Patient was taking Rifater (View Usage). Patient had the following side effects: hypoacusis, hypoaesthesia, neuritis cranial, optic neuritis, visual acuity reduced on May 27, 2005 from Additional patient health information: Female patient , 40 years of age, was diagnosed with pulmonary tuberculosis and. Rifater dosage: . During the same period patient was treated with INNOHEP (View Innohep Review and Innohep Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), COMBIVIR (View Combivir Review and Combivir Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.